Kasthuraiah Maddali

发表

Development and pharmacologic characterization of deoxybromophospha sugar derivatives with antileukemic activity

M. Yamashita,, M. Fujie, Satoki Nakamura, 2010, Investigational New Drugs.

Activities, crystal structures, and molecular dynamics of dihydro-1H-isoindole derivatives, inhibitors of HIV-1 integrase.

Y. Pommier, S. Hughes, Steven J Smith, 2013, ACS chemical biology.

2,3-dihydro-6,7-dihydroxy-1H-isoindol-1-one-based HIV-1 integrase inhibitors.

Y. Pommier, S. Hughes, C. Marchand, 2008, Journal of medicinal chemistry.

Elvitegravir overcomes resistance to raltegravir induced by integrase mutation Y143

Y. Pommier, M. Métifiot, Xuemin Zhang, 2011, AIDS.

Development of tricyclic hydroxy-1H-pyrrolopyridine-trione containing HIV-1 integrase inhibitors.

Y. Pommier, S. Hughes, Steven J Smith, 2011, Bioorganic & medicinal chemistry letters.

Biological evaluation of imidazolium- and ammonium-based salts as HIV-1 integrase inhibitors

Y. Pommier, C. Marchand, S. Malhotra, 2011 .

Diketoacid-genre HIV-1 integrase inhibitors containing enantiomeric arylamide functionality.

Yves Pommier, Xue Zhi Zhao, Y. Pommier, 2009, Bioorganic & medicinal chemistry.

Examination of halogen substituent effects on HIV-1 integrase inhibitors derived from 2,3-dihydro-6,7-dihydroxy-1H-isoindol-1-ones and 4,5-dihydroxy-1H-isoindole-1,3(2H)-diones.

Stephen H Hughes, Yves Pommier, Xue Zhi Zhao, 2009, Bioorganic & medicinal chemistry letters.

6,7-Dihydroxyisoindolin-1-one and 7,8-Dihydroxy-3,4-Dihydroisoquinolin- 1(2H)-one Based HIV-1 Integrase Inhibitors.

Y. Pommier, S. Hughes, Steven J Smith, 2015, Current topics in medicinal chemistry.

Studies of HIV Integrase Inhibitory Activity of Morinda citrifolia L Noni Fruit Extracts

Y. Pommier, P. Selvam, C. Marchand, 2010 .

Basic Quinolinonyl Diketo Acid Derivatives as Inhibitors of HIV Integrase and their Activity against RNase H Function of Reverse Transcriptase

Y. Pommier, E. Novellino, S. L. Le Grice, 2014, Journal of medicinal chemistry.

6-Benzoyl-3-hydroxypyrimidine-2,4-diones as dual inhibitors of HIV reverse transcriptase and integrase.

Y. Pommier, Y. Sham, Jing Tang, 2011, Bioorganic & medicinal chemistry letters.

3-Hydroxypyrimidine-2,4-diones as an inhibitor scaffold of HIV integrase.

Yves Pommier, Y. Pommier, Y. Sham, 2011, Journal of medicinal chemistry.

N-3 Hydroxylation of Pyrimidine-2,4-diones Yields Dual Inhibitors of HIV Reverse Transcriptase and Integrase.

Y. Pommier, Y. Sham, Jing Tang, 2011, ACS medicinal chemistry letters.

The Twenty-Third International Conference on Antiviral Research

X. Chen, Y. Pommier, D. Smee, 2010, Antiviral Research.

Scaffold rearrangement of dihydroxypyrimidine inhibitors of HIV integrase: Docking model revisited.

Y. Pommier, Y. Sham, Jing Tang, 2010, Bioorganic & medicinal chemistry letters.

Preparation And Characterization Of Phospholanes And Phospha Sugars As Novel Anti-Cancer Agents

S. Ito, M. Yamashita,, M. Fujie, 2009 .

HIV-1 IN inhibitors: 2010 update and perspectives.

Yves Pommier, Y. Pommier, M. Métifiot, 2009, Current topics in medicinal chemistry.

Probing chelation motifs in HIV integrase inhibitors

Douglas D. Richman, Yves Pommier, Arpita Agrawal, 2012, Proceedings of the National Academy of Sciences.

Resistance to Integrase Inhibitors

Y. Pommier, M. Métifiot, C. Marchand, 2010, Viruses.

Role of tyrosyl-DNA phosphodiesterase (TDP1) in mitochondria

Y. Pommier, T. Dexheimer, B. Das, 2010, Proceedings of the National Academy of Sciences.

Preparation and Characterization of Phospha Sugar Analogues, 2,3-Dibromo-3-methyl-1- phenylphospholane 1-Oxide Derivatives, as Novel Anticancer Agents

M. Yamashita,, M. Fujie, M. Yamada, 2010 .

Preparation and characterization of novel 4-bromo-3,4-dimethyl-1-phenyl-2-phospholene 1-oxide and the analogous phosphorus heterocycles or phospha sugars.

M. Yamashita,, M. Fujie, M. Yamada, 2010, Bioorganic & medicinal chemistry letters.

Synthesis of Some 1-Aryl-2,3-dibromophospholanes as Novel Anti-Cancer Agents

Yasutaka Tanaka, M. Yamashita,, M. Fujie, 2010 .

Bicyclic Hydroxy‐1H‐pyrrolopyridine‐trione Containing HIV‐1 Integrase Inhibitors

Y. Pommier, S. Hughes, M. Métifiot, 2012, Chemical biology & drug design.

Biochemical and pharmacological analyses of HIV-1 integrase flexible loop mutants resistant to raltegravir.

Yves Pommier, Y. Pommier, M. Métifiot, 2010, Biochemistry.

HIV-1 Integrase-Targeted Short Peptides Derived from a Viral Protein R Sequence

Y. Pommier, M. Métifiot, M. Kvaratskhelia, 2018, Molecules.

Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.

Y. Pommier, T. Narumi, H. Tamamura, 2010, Bioorganic & medicinal chemistry.

Peptide HIV-1 integrase inhibitors from HIV-1 gene products.

Y. Pommier, W. Sugiura, T. Narumi, 2010, Journal of medicinal chemistry.

Cell-permeable stapled peptides based on HIV-1 integrase inhibitors derived from HIV-1 gene products.

Y. Pommier, T. Narumi, H. Tamamura, 2013, ACS chemical biology.

6,7-Dihydroxy-1-oxoisoindoline-4-sulfonamide-containing HIV-1 integrase inhibitors.

Y. Pommier, S. Hughes, M. Métifiot, 2012, Bioorganic & medicinal chemistry letters.

Elvitegravir overcomes resistance to raltegravir induced by integrase mutation Y143

Y. Pommier, M. Métifiot, Xuemin Zhang, 2011, AIDS.